ONO-1603 is a prolyl endopeptidase inhibitor potentially for the treatment of Alzheimer's disease. References: Katsube N, Sunaga K, Aishita H, Chuang DM, Ishitani R. ONO-1603, a potential antidementia drug, delays age-induced apoptosis and suppresses overexpression of glyceraldehyde-3-phosphate dehydrogenase in cultured central nervous system neurons. J Pharmacol Exp Ther. 1999 Jan;288(1):6-13. PubMed PMID: 9862746.

纯度：≥98%

CAS：117427-00-6